We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

High Risk Breast Cancer Screening Program

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified May 2012 by Organisation for Oncology and Translational Research.
Recruitment status was:  Recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT00509509
First Posted: July 31, 2007
Last Update Posted: May 24, 2012
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Organisation for Oncology and Translational Research
  Purpose

Objectives:

  • To screen population with high risk for breast cancer
  • To promote the concept and importance of surveillance mammography
  • To find out the incidence of breast cancer in population who are in high risk for breast cancer
  • To collect blood samples for molecular analysis

Condition
Breast Cancer

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: High Risk Breast Cancer Screening Program

Resource links provided by NLM:


Further study details as provided by Organisation for Oncology and Translational Research:

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   41 Years and older   (Adult, Senior)
Sexes Eligible for Study:   Female
Sampling Method:   Probability Sample
Study Population
Women aged over 40 with high risk of breast cancer
Criteria

Inclusion Criteria:

  • Female
  • > 40 years of age
  • Women who have first-degree relative suffered from breast cancer
  • Women who have first-degree relative suffered from ovarian cancer
  • Family history of male breast cancer
  • Family history of breast cancer (not necessarily first degree relatives) diagnosed before age of 40
  • Family history of breast cancer (not necessarily first degree relatives) affecting 2 or more family members
  • Personal history of ovarian cancer
  • Personal history of premalignant conditions of breast and ovary

Exclusion Criteria:

  • Women with mammogram within one year
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00509509


Contacts
Contact: Louis WC Chow (852)2861 0286 lwcchow@unimed.hk

Locations
Hong Kong
UNIMED Medical Institute Recruiting
Wanchai, Hong Kong
Contact: Louis WC Chow    (852)2861 0286    lwcchow@unimed.hk   
Sponsors and Collaborators
Organisation for Oncology and Translational Research
Investigators
Principal Investigator: Louis WC Chow UNIMED Medical Institute
  More Information

ClinicalTrials.gov Identifier: NCT00509509     History of Changes
Other Study ID Numbers: OOTR-SBR001
First Submitted: July 29, 2007
First Posted: July 31, 2007
Last Update Posted: May 24, 2012
Last Verified: May 2012

Keywords provided by Organisation for Oncology and Translational Research:
Hereditary Breast Cancer (BRCA1, BRCA2)

Additional relevant MeSH terms:
Breast Neoplasms
Neoplasms by Site
Neoplasms
Breast Diseases
Skin Diseases